Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-02 4:38 pm Purchase |
2024-01-31 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 315,804 40.300% |
122,000 (+62.95%) |
Filing History |
| 2024-01-25 5:21 pm Purchase |
2024-01-23 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 193,804 29.400% |
193,804 (New Position) |
Filing History |
| 2022-11-15 4:30 pm Purchase |
2022-11-11 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 292,144 43.200% |
9,689 (+3.43%) |
Filing History |
| 2022-04-28 07:00 am Purchase |
2022-04-26 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 282,455 43.200% |
20,712 (+7.91%) |
Filing History |
| 2021-08-04 09:35 am Purchase |
2021-07-30 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 261,744 42.300% |
797 (+0.31%) |
Filing History |
| 2021-06-25 4:30 pm Purchase |
2021-06-14 | 13D | Alzamend Neuro, Inc. ALZN |
AULT MILTON C III | 260,947 41.600% |
260,947 (New Position) |
Filing History |